Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Grant of options...

<< Previous

Bullboard Posts

Next >>

Comment by SundayMovieson Dec 13, 2022 1:33pm

139 Views

Post# 35168967

RE:RE:RE:Grant of options...

No Cdn value = 2.31.

So, management is giving themselve 2.31 options. They pricing a bottom.

So we have a solid floor at 2.31$ Cdn.

Let's see how the market react from here. It should help us rise further up.

This also explain why SP dipped from earlier.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing